{
  "url": "https://openlegislation.uk/eu-regulation-2018-660/annex-II",
  "json_url": "https://openlegislation.uk/eu-regulation-2018-660/annex-II.json",
  "legislation": "eur/2018/660",
  "legislation_title": "Commission Implementing Regulation (EU) 2018/660 of 26 April 2018 renewing the approval of the active substance bentazone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2018-660",
  "path": "annex/II",
  "kind": "annex",
  "number": "II",
  "heading": null,
  "text": "The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:\n(1) in Part A, entry 11 on bentazone is deleted;\n(2) in Part B, the following entry is added:\nFurther details on the identity and specification of the active substance are provided in the review report.\nNumber\nCommon Name, Identification Numbers\nIUPAC Name\nPurity\nDate of approval\nExpiration of approval\nSpecific provisions\n‘120\nBentazone\nCAS No 25057-89-0\nCIPAC No 366\n3-isopropyl-1H-2,1,3-benzothiadiazin-4(3H)-one 2,2- dioxide\n≥ 960 g/kg\n1,2-dichloroethane < 3 mg/kg\n1 June 2018\n31 May 2025\nFor the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on bentazone, and in particular Appendices I and II thereof, shall be taken into account.\nIn their overall assessment Member States shall pay particular attention to:\nthe technical specification,\nthe protection of operators and workers,\nthe risk to birds and mammals,\nthe protection of groundwater, particularly but not only in drinking water protected areas, and shall carefully consider the timing of application, soil and/or climatic conditions.\nConditions of use shall include risk mitigation measures where appropriate.\nThe applicant shall submit by 1 February 2019 to the Commission, the Member States and the Authority confirmatory information as regards Level 2/3 tests as currently indicated in the OECD Conceptual Framework investigating the potential for endocrine-mediated effects of bentazone.’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Further details on the identity and specification of the active substance are provided in the review report."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2018/660/annex/II",
    "retrieved_at": "2026-11-01T14:44:10.516461+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}